DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Filed by the Registrant    ☒                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12

BIOGEN INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  1)  

Title of each class of securities to which transaction applies:

 

  2)  

Aggregate number of securities to which transaction applies:

 

  3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

  4)  

Proposed maximum aggregate value of transaction:

 

  5)  

Total fee paid:

 

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  1)  

Amount Previously Paid:

 

  2)  

Form, Schedule or Registration Statement No.:

 

  3)  

Filing Party:

 

  4)  

Date Filed:

 

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on June 19, 2019.

 

 

BIOGEN INC.

 

LOGO

 

BIOGEN INC.

225 BINNEY STREET

CAMBRIDGE, MA 02142

 
 
 
 
 
 
 
 
 
 
 
LOGO  
 
 
 
 
 
 
 

 

Meeting Information

 

Meeting Type:        Annual Meeting

 

For holders as of:   April 22, 2019

 

Date: June 19, 2019  Time:  9:00 a.m. Eastern Time

 

Location:    Biogen Inc.

                     225 Binney Street

                     Cambridge, Massachusetts 02142

 

                     Meeting live via the Internet-please visit

                      www.virtualshareholdermeeting.com/BIIB2019

 

You are receiving this communication because you hold shares in the company named above.

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 


— Before You Vote —

How to Access the Proxy Materials

 

  

 

Proxy Materials Available to VIEW or RECEIVE:

    
   2019 NOTICE AND PROXY STATEMENT             2018 ANNUAL REPORT WITH FORM 10-K    
  

 

How to View Online:

   
   Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.    
  

 

How to Request and Receive a PAPER or E-MAIL Copy:

   
   If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:    
  

 

1) BY INTERNET:

  

 

www.proxyvote.com

   
  

2) BY TELEPHONE:

   1-800-579-1639    
  

3) BY E-MAIL*:

   sendmaterial@proxyvote.com    
  

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 5, 2019 to facilitate timely delivery.

 

   
  

 

— How To Vote —

Please Choose One of the Following Voting Methods

 

 
  

 

Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

   
  

 

Vote By Internet:

     
LOGO   

Before The Meeting:

  Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.    
  

 

During The Meeting:

 

 

Go to www.virtualshareholdermeeting.com/BIIB2019. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

   
  

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

   


  Voting Items   
  The Board recommends a vote FOR the following proposals:
  1.    Election of Directors. To elect the fourteen director nominees numbered 1a through 1n to serve for a one-year term extending until the 2020 annual meeting of stockholders and their successors are duly elected and qualified.
     1a.    John R. Chiminski
     1b.    Alexander J. Denner
     1c.    Caroline D. Dorsa
     1d.    William A. Hawkins
     1e.    Nancy L. Leaming
     1f.    Jesus B. Mantas
     1g.    Richard C. Mulligan
     1h.    Robert W. Pangia
     1i.    Stelios Papadopoulos
     1j.    Brian S. Posner
     1k.    Eric K. Rowinsky
LOGO        
       
       
       
       

 

 

     1l.    Lynn Schenk
     1m.    Stephen A. Sherwin
     1n.    Michel Vounatsos

 

2.    To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
3.    Say on Pay - To approve an advisory vote on executive compensation.
 


 

 

 

 

 

 

    

LOGO